Literature DB >> 12034043

Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives.

Robert Kleemann1, Matthias Grell, Ralf Mischke, Gudrun Zimmermann, Jürgen Bernhagen.   

Abstract

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine for which a receptor has not been identified. That MIF has intracellular functions has been suggested by its enzymatic activity and constitutive expression profile. The discovery of functional MIF-c-Jun activation domain binding protein 1 (JAB1) binding has confirmed this notion and indicated that nonreceptor-based signaling mechanisms are important for MIF function. Here, we have generated and tested several biologically active labeled MIF derivatives to further define target protein binding by MIF and its cellular uptake characteristics. (35)S-MIF, biotinylated MIF, and fluoresceinated MIF were demonstrated to exhibit full biologic activity. Neither by applying a standard iodinated MIF preparation nor by using the biologically active (35)S-MIF derivative in receptor-binding studies were we able to measure any receptor-binding activity on numerous cells, confirming that uptake of MIF into target cells and MIF signaling can occur by receptor-independent pathways. When MIF derivatives were applied in cellular uptake studies, MIF was found to be endocytosed into both immune and nonimmune cells and targeted to the cytosol and lysosomes. The entry of MIF was temperature and energy dependent and was inhibited by monodansylcadaverine but not by ouabain. Endocytosed biotin-MIF bound JAB1 not only in macrophages, as shown previously, but also in nonimmune cells. A tagged MIF construct, MIF-enhanced green fluorescent protein (EGFP), was shown to be a valuable tool, as EGFP constructs of critical MIF cysteine mutants exhibited identical cellular localization properties to those of wild-type MIF (wtMIF). Our results indicate that MIF membrane receptors are not widely expressed, if at all, and suggest that the cellular uptake of MIF occurs by nonreceptor-mediated endocytosis rather than penetration. All the derivatives investigated, except for iodinated MIF, represent valuable tools for further MIF target protein and cellular studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034043     DOI: 10.1089/107999002753675785

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  12 in total

1.  Spirohexenolide A targets human macrophage migration inhibitory factor (hMIF).

Authors:  Wei-Lun Yu; Brian D Jones; Minjin Kang; Justin C Hammons; James J La Clair; Michael D Burkart
Journal:  J Nat Prod       Date:  2013-05-09       Impact factor: 4.050

Review 2.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

3.  Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.

Authors:  Ana R Inácio; Karsten Ruscher; Lin Leng; Richard Bucala; Tomas Deierborg
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-10       Impact factor: 6.200

Review 4.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

Review 5.  CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

6.  Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.

Authors:  Kersten Berndt; Marcus Kim; Andreas Meinhardt; Jörg Klug
Journal:  Mol Cell Biochem       Date:  2007-09-05       Impact factor: 3.396

7.  Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.

Authors:  Yuhuan Zheng; Qiang Wang; Tianshu Li; Jianfei Qian; Yong Lu; Yi Li; Enguang Bi; Frederic Reu; Yu Qin; Judy Drazba; Eric Hsi; Jing Yang; Zhen Cai; Qing Yi
Journal:  J Natl Cancer Inst       Date:  2016-07-05       Impact factor: 13.506

8.  β-Arrestin1 mediates the endocytosis and functions of macrophage migration inhibitory factor.

Authors:  Lishi Xie; Xiaohang Qiao; Yanfang Wu; Jie Tang
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

Review 9.  Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.

Authors:  Kyoung-Woon Kim; Hae-Rim Kim
Journal:  Korean J Intern Med       Date:  2016-05-12       Impact factor: 2.884

Review 10.  Cytokines and atherosclerosis: a comprehensive review of studies in mice.

Authors:  Robert Kleemann; Susanne Zadelaar; Teake Kooistra
Journal:  Cardiovasc Res       Date:  2008-05-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.